Coeptis Therapeutics, Inc. (COEP)
USD 9.75
(2.85%)
USD 9.75
(2.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -21.49 Million USD | 37.15% |
| 2022 | -34.19 Million USD | -143.46% |
| 2021 | -14.04 Million USD | -104.71% |
| 2020 | -6.86 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2005 | -308.3 Thousand USD | -2959.49% |
| 2004 | -10.07 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.82 Million USD | 3.23% |
| 2024 Q1 | -2.92 Million USD | 13.18% |
| 2023 Q2 | -3.63 Million USD | 43.59% |
| 2023 Q1 | -6.44 Million USD | -111.92% |
| 2023 FY | -21.49 Million USD | 37.15% |
| 2023 Q4 | -3.36 Million USD | 57.02% |
| 2023 Q3 | -7.83 Million USD | -115.27% |
| 2022 Q4 | -3.04 Million USD | 45.35% |
| 2022 Q3 | -5.56 Million USD | 43.25% |
| 2022 Q2 | -9.81 Million USD | 37.78% |
| 2022 Q1 | -15.77 Million USD | -432.63% |
| 2022 FY | -34.19 Million USD | -143.46% |
| 2021 Q3 | -6.94 Million USD | -164.78% |
| 2021 FY | -14.04 Million USD | -104.71% |
| 2021 Q1 | -1.7 Million USD | -248.83% |
| 2021 Q2 | -2.62 Million USD | -54.35% |
| 2021 Q4 | -2.96 Million USD | 57.38% |
| 2020 FY | -6.86 Million USD | 0.0% |
| 2020 Q4 | -487.36 Thousand USD | -3922.83% |
| 2020 Q3 | -12.11 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2005 FY | -308.3 Thousand USD | -2959.49% |
| 2005 Q1 | -32.00 USD | 0.0% |
| 2005 Q2 | -174.07 Thousand USD | -543896.88% |
| 2005 Q4 | -134.22 Thousand USD | -1443.54% |
| 2005 Q3 | -8696.00 USD | 95.0% |
| 2004 FY | -10.07 Thousand USD | 0.0% |
| 2004 Q4 | - USD | 100.0% |
| 2004 Q3 | -9722.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1509.302% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -326.032% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -20.419% |
| Nascent Biotech, Inc. | -2.22 Million USD | -863.78% |
| Rebus Holdings, Inc. | -664 Thousand USD | -3136.614% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 126.256% |
| Qrons Inc. | -643.67 Thousand USD | -3238.805% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -5416.626% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 61.283% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -5072.613% |
| Skye Bioscience, Inc. | -13.67 Million USD | -57.193% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 70.062% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 537.273% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -8111.305% |
| SQZ Biotechnologies Company | -75.82 Million USD | 71.657% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -653.94% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1299.117% |
| Mesoblast Limited | -84.14 Million USD | 74.46% |
| Marizyme, Inc. | -34.08 Million USD | 36.951% |
| Genus plc | 6.4 Million USD | 435.799% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 320.592% |
| Pharming Group N.V. | -4.87 Million USD | -340.433% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -981.87% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -2207.449% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -157.379% |
| ContraFect Corporation | -56.88 Million USD | 62.223% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -371.842% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1432.9% |
| IMV Inc. | -38.67 Million USD | 44.426% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -681.257% |
| MultiCell Technologies, Inc. | -722.81 USD | -2973173.751% |
| ONE Bio Corp. | 13.68 Million USD | 257.081% |
| Accustem Sciences Inc. | -3.74 Million USD | -473.644% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 63.568% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -4348.936% |
| Q BioMed Inc. | -3.44 Million USD | -523.724% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 707.094% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -717.924% |
| Biomind Labs Inc. | -1 Million USD | -2028.67% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 60.906% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -640.754% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -223.271% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -1052.728% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -71651.87% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -35.422% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -1012.026% |
| GB Sciences, Inc. | -1.42 Million USD | -1412.917% |
| Alpha Cognition Inc. | -9.7 Million USD | -121.43% |
| HST Global, Inc. | -140.9 Thousand USD | -15151.989% |
| CSL Limited | 3.7 Billion USD | 100.581% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -1810.481% |
| Halberd Corporation | -75.05 Thousand USD | -28535.736% |
| Enzolytics Inc. | -2.14 Million USD | -900.145% |
| Agentix Corp. | -1.37 Million USD | -1466.687% |
| Resverlogix Corp. | -12.74 Million USD | -68.571% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -578.323% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 94.944% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -1958.536% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -636.137% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -1260.753% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -531.167% |
| AVAX Technologies, Inc. | 6.69 Million USD | 421.104% |
| Zenith Capital Corp. | -8.94 Million USD | -140.312% |
| Genscript Biotech Corporation | -415.79 Million USD | 94.831% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -123263.297% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -775.289% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -12430.568% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -972.006% |
| Kadimastem Ltd | -3.04 Million USD | -606.887% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -2083.939% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -1611.076% |
| BioStem Technologies, Inc. | -7.77 Million USD | -176.272% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -11741.816% |
| LadRx Corporation | -3.82 Million USD | -462.061% |
| Cell Source, Inc. | -4.32 Million USD | -396.865% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -3028.484% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -3028.484% |
| NovAccess Global Inc. | -2.46 Million USD | -771.229% |
| Affymax, Inc. | -15.04 Million USD | -42.836% |
| Itoco Inc. | -919.14 Thousand USD | -2238.177% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -407.056% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1820.565% |
| Mobile Lads Corp. | -554.55 Thousand USD | -3775.416% |
| CytoDyn Inc. | -18.05 Million USD | -19.012% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -85283.87% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -9665.229% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -3705.604% |
| SYBLEU INC | -149.18 Thousand USD | -14306.167% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -1083.223% |
| International Stem Cell Corporation | -663 Thousand USD | -3141.496% |
| Bioxytran, Inc. | -3.82 Million USD | -462.573% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -40726.596% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -105559.39% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 40.74% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -1228.252% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -2820.644% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -590.811% |
| Neutra Corp. | -229.48 Thousand USD | -9264.894% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -22.533% |
| PureTech Health plc | -146.19 Million USD | 85.3% |
| IXICO plc | -1.43 Million USD | -1395.555% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -126.437% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 82.356% |
| CSL Limited | 3.81 Billion USD | 100.564% |
| Cellectis S.A. | -108.85 Million USD | 80.258% |